Dopaminergic Pathway Genes Influence Adverse Events Related to Dopaminergic Treatment in Parkinson's Disease

• Main Authors: Sara Redenšek (Author), Dušan Flisar (Author), Maja Kojović (Author), Milica Gregorič Kramberger (Author), Dejan Georgiev (Author), Zvezdan Pirtošek (Author), Maja Trošt (Author), Vita Dolžan (Author)
• Format: Book
• Published: Frontiers Media S.A., 2019-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Dopaminergic pathway is the most disrupted pathway in the pathogenesis of Parkinson's disease. Several studies reported associations of dopaminergic genes with the occurrence of adverse events of dopaminergic treatment. However, none of these studies adopted a pathway based approach. The aim of...